Biogen Inc Stock Price on September 4, 2024
| BIIB Stock | USD 157.90 0.11 0.07% |
Below is the normalized historical share price chart for Biogen Inc extending back to September 17, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biogen stands at 157.90, as last reported on the 25th of November, with the highest price reaching 159.72 and the lowest price hitting 157.28 during the day.
If you're considering investing in Biogen Stock, it is important to understand the factors that can impact its price. Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Risk Adjusted Performance of (0.22), standard deviation of 1.29, and Mean Deviation of 0.9972 to double-check the risk estimate we provide.
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B). . At present, Biogen's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 31.81, whereas Price To Sales Ratio is forecasted to decline to 3.62. Biogen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of September 1991 | 200 Day MA 207.8082 | 50 Day MA 181.8416 | Beta (0.06) |
Biogen |
Sharpe Ratio = -0.2961
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIIB |
Estimated Market Risk
| 1.3 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.3 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding Biogen to a well-diversified portfolio.
Price Book 1.4065 | Enterprise Value Ebitda 9.996 | Price Sales 2.3949 | Shares Float 145.2 M | Wall Street Target Price 251.6969 |
Biogen Valuation on September 4, 2024
It is possible to determine the worth of Biogen on a given historical date. On September 4, 2024 Biogen was worth 205.72 at the beginning of the trading date compared to the closed value of 204.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biogen stock. Still, in general, we apply an absolute valuation method to find Biogen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biogen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biogen's related companies.
| Open | High | Low | Close | Volume | |
| 204.22 | 206.70 | 203.51 | 204.84 | 870,916 | |
09/04/2024 | 205.72 | 206.50 | 203.53 | 204.95 | 749,227 |
| 205.19 | 205.19 | 198.19 | 201.80 | 1,093,662 |
| Backtest Biogen | | | Biogen History | | | Biogen Valuation | Previous | Next |
Biogen Trading Date Momentum on September 4, 2024
| On September 05 2024 Biogen Inc was traded for 201.80 at the closing time. The top price for the day was 205.19 and the lowest listed price was 198.19 . The trading volume for the day was 1.1 M. The trading history from September 5, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.54% . The overall trading delta against the current closing price is 3.93% . |
Biogen Inc Fundamentals Correlations and Trends
By evaluating Biogen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biogen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biogen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Biogen Stock history
Biogen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biogen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biogen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biogen stock prices may prove useful in developing a viable investing in Biogen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 145.6 M | 283 M | |
| Net Income Applicable To Common Shares | 3.5 B | 2 B |
Biogen Quarterly Net Working Capital |
|
Biogen Stock Technical Analysis
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biogen Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Biogen Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Biogen November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Biogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biogen shares will generate the highest return on investment. By undertsting and applying Biogen stock market strength indicators, traders can identify Biogen Inc entry and exit signals to maximize returns
Biogen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biogen's price direction in advance. Along with the technical and fundamental analysis of Biogen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biogen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.22) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.57) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |